UPMC Enterprises has contributed to a series B round for Sempre Health, which is building a platform to make drugs more affordable for patients.

Morningside Venture Investments has led a series B round for the fibrotic diseases-focused spinout that advances University of Strasbourg research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The immuno-oncology therapy developer has amassed at least $190m of overall funding since emerging out of Stanford University.

Helsinki spinout Aiforia has raised an initial $15.4m in series B funding, bringing it halfway to the round’s target.

The Tsinghua-backed DNA and RNA sequencing equipment manufacturer has added $63m to its coffers.

The low Earth orbit mapping technology provider has raised more than $100m altogether, having picked up series A financing from Weru Investment in 2018.

Hokkaido spinout AWL has collected fresh funding from a consortium led by Rakuten Capital.

Main Sequence Ventures-backed Amber has closed a $15.5m series B round led by Commonwealth Bank.

ANU Connect Ventures has participated in a series B round for Liquid Instruments, which builds on research at Australian National University.